comparemela.com

Latest Breaking News On - Neogenomics company profile - Page 3 : comparemela.com

NeoGenomics, Inc. (NASDAQ:NEO) Given Consensus Rating of "Moderate Buy" by Brokerages

NeoGenomics, Inc. (NASDAQ:NEO) Given Consensus Rating of "Moderate Buy" by Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
United-states
Aliciac-olivo
Piper-sandler
William-blair
Capital-partners
Neogenomics-company-profile
Financial-services-group-inc
Group-plc
Clinical-services
Goldman-sachs-group
Dell-group

Aigen Investment Management LP Makes New Investment in NeoGenomics, Inc. (NASDAQ:NEO)

Aigen Investment Management LP acquired a new position in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) in the third quarter, according to its most recent disclosure with the SEC. The firm acquired 13,232 shares of the medical research company’s stock, valued at approximately $163,000. Other hedge funds also recently added to or reduced their […]

United-states
Rkestra
Russia-general
Russia
Aliciac-olivo
Piper-sandler
Skandinaviska-enskilda-banken
Neogenomics-company-profile
Neogenomics-inc
Kestra-advisory-services
Envestnet-asset-management-inc
Clinical-services

NeoGenomics (NASDAQ:NEO) Rating Reiterated by William Blair

William Blair reaffirmed their outperform rating on shares of NeoGenomics (NASDAQ:NEO – Free Report) in a research report report published on Wednesday, RTT News reports. William Blair also issued estimates for NeoGenomics’ Q1 2025 earnings at ($0.04) EPS, Q2 2025 earnings at ($0.03) EPS, Q3 2025 earnings at ($0.01) EPS, Q4 2025 earnings at $0.02 […]

United-states
Aliciac-olivo
William-blair
Burkett-financial-services
Morgan-stanley
Pharma-services
Neogenomics-inc
O-dell-group
Clinical-services
Coppell-advisory-solutions
Neogenomics-company-profile
Needham-company

NeoGenomics, Inc. (NASDAQ:NEO) General Counsel Sells $38,701.52 in Stock

NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) General Counsel Alicia C. Olivo sold 2,587 shares of the stock in a transaction dated Thursday, February 15th. The shares were sold at an average price of $14.96, for a total value of $38,701.52. Following the completion of the transaction, the general counsel now owns 34,866 shares of […]

United-states
Aliciac-olivo
William-blair
Neogenomics-inc
Neogenomics-company-profile
Alphacrest-capital-management
Citigroup-inc
Goldman-sachs-group
Clinical-services
Nasdaq
Pharma-services
Securities-exchange-commission

Illinois Municipal Retirement Fund Makes New $960,000 Investment in NeoGenomics, Inc. (NASDAQ:NEO)

Illinois Municipal Retirement Fund acquired a new position in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 78,076 shares of the medical research company’s stock, valued at approximately $960,000. Illinois Municipal Retirement Fund owned approximately 0.06% […]

United-kingdom
Texas
United-states
Illinois
Aliciac-olivo
Piper-sandler
Mitsubishi-ufj
Neogenomics-inc
Exchange-commission
Asset-management-united-kingdom-ltd
Td-asset-management-inc
Pharma-services

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.